Longboard Pharmaceuticals Inc. Gains 316.25%

Tue, Jan 02, 2024 at 07:39 PM

Longboard Pharmaceuticals Inc. (LBPH:NASDAQ) rocketted at $25.1, representing a gain of 316.3%. On Tue, Jan 02, 2024, LBPH:NASDAQ touched a New 2-Week High of $25.1. The stock got featured on our News Catalysts scanner on Tue, Jan 02, 2024 at 06:32 PM in the 'PUBLIC OFFERING' category. From Wed, Dec 20, 2023, the stock recorded 71.43% Up Days and 50.00% Green Days

About Longboard Pharmaceuticals Inc. (LBPH:NASDAQ)

Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases.

Top 10 Gainers:

Longboard Pharmaceuticals Inc. (LBPH:NASDAQ), 316.25%
Akso Health Group (AHG:NASDAQ), 61.2%
Dogness (International) Corporation (DOGZ:NASDAQ), 54.73%
Polished Inc Com (POL:NYSEMKT), 52.24%
VolitionRx Limited (VNRX:NYSEMKT), 46.44%
NGM Biopharmaceuticals, Inc. (NGM:NASDAQ), 45.52%
PolyPid Ltd. (PYPD:NASDAQ), 43.42%
Kelso Technologies Inc. (KIQ:NYSEMKT), 42.17%
Peak Bio Inc Com (PKBO:NASDAQ), 41.15%
Cue Health Inc. (HLTH:NASDAQ), 40.43%